Efficacy and Safety of a Second Adalimumab Treatment Cycle in Psoriasis Patients who Relapsed after Adalimumab Discontinuation or Dosage Reduction: A Double-Blind, Randomized, Placebo-Controlled Trial

Amir Larian,Jason Emer,Kenneth B. Gordon,Robin R. Blum,Martin M. Okun,Yihua Gu,Mark Lebwohl

Efficacy and Safety of a Second Adalimumab Treatment Cycle in Psoriasis Patients who Relapsed after Adalimumab Discontinuation or Dosage Reduction: A Double-Blind, Randomized, Placebo-Controlled Trial

2011

Amir Larian
Jason Emer
Kenneth B. Gordon
Robin R. Blum
Martin M. Okun
Yihua Gu
Mark Lebwohl

ObjectiveTo evaluate re-treatment with weekly adalimumab in patients with moderate to severe psoriasis who had been successfully treated with weekly adalimumab but relapsed following randomization ...

Keywords:

Psoriasis
Discontinuation
Adalimumab
Physical therapy
Medicine
Placebo-controlled study
double blind
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations